166 related articles for article (PubMed ID: 23877652)
1. Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases.
Zenda S; Nakagami Y; Toshima M; Arahira S; Kawashima M; Matsumoto Y; Kinoshita H; Satake M; Akimoto T
Int J Clin Oncol; 2014 Aug; 19(4):739-43. PubMed ID: 23877652
[TBL] [Abstract][Full Text] [Related]
2. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract][Full Text] [Related]
3. Strontium 89 therapy for the palliation of pain due to osseous metastases.
Robinson RG; Preston DF; Schiefelbein M; Baxter KG
JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
[TBL] [Abstract][Full Text] [Related]
4. Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.
Kraeber-Bodéré F; Campion L; Rousseau C; Bourdin S; Chatal JF; Resche I
Eur J Nucl Med; 2000 Oct; 27(10):1487-93. PubMed ID: 11083537
[TBL] [Abstract][Full Text] [Related]
5. Strontium-89 for palliation of pain from bone metastases in patients with prostate and breast cancer.
Pons F; Herranz R; Garcia A; Vidal-Sicart S; Conill C; Grau JJ; Alcover J; Fuster D; Setoain J
Eur J Nucl Med; 1997 Oct; 24(10):1210-4. PubMed ID: 9323260
[TBL] [Abstract][Full Text] [Related]
6. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.
Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J
Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585
[TBL] [Abstract][Full Text] [Related]
7. Strontium chloride Sr 89 for treating pain from metastatic bone disease.
Nightengale B; Brune M; Blizzard SP; Ashley-Johnson M; Slan S
Am J Health Syst Pharm; 1995 Oct; 52(20):2189-95. PubMed ID: 8564588
[TBL] [Abstract][Full Text] [Related]
8. Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases.
Baba K; Kaida H; Hattori C; Muraki K; Kugiyama T; Fujita H; Ishibashi M
Hell J Nucl Med; 2018; 21(1):15-23. PubMed ID: 29550842
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of strontium-89 chloride in treating bone metastasis of lung, breast, and prostate cancers.
Ye X; Sun D; Lou C
J Cancer Res Ther; 2018; 14(Supplement):S36-S40. PubMed ID: 29578147
[TBL] [Abstract][Full Text] [Related]
10. Strontium-89 chloride in the treatment of bone metastases from breast cancer.
Baziotis N; Yakoumakis E; Zissimopoulos A; Geronicola-Trapali X; Malamitsi J; Proukakis C
Oncology; 1998; 55(5):377-81. PubMed ID: 9732212
[TBL] [Abstract][Full Text] [Related]
11. EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.
Kurosaka S; Satoh T; Chow E; Asano Y; Tabata K; Kimura M; Tsumura H; Matsumoto K; Ishiyama H; Inoue Y; Hayakawa K; Baba S
Ann Nucl Med; 2012 Jul; 26(6):485-91. PubMed ID: 22477263
[TBL] [Abstract][Full Text] [Related]
12. Strontium-89 therapy and imaging with bremsstrahlung in bone metastases.
Uchiyama M; Narita H; Makino M; Sekine H; Mori Y; Fukumitsu N; Kawakami K
Clin Nucl Med; 1997 Sep; 22(9):605-9. PubMed ID: 9298293
[TBL] [Abstract][Full Text] [Related]
13. Strontium-89 chloride delivery for painful bone metastases in patients with a history of prior irradiation.
Saito AI; Inoue T; Kinoshita M; Kosaka T; Mitsuhashi T
Ir J Med Sci; 2023 Apr; 192(2):569-574. PubMed ID: 35538276
[TBL] [Abstract][Full Text] [Related]
14. (153)Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies.
Correa-González L; Arteaga de Murphy C; Pichardo-Romero P; Pedraza-López M; Moreno-García C; Correa-Hernández L
Arch Med Res; 2014 May; 45(4):301-8. PubMed ID: 24681187
[TBL] [Abstract][Full Text] [Related]
15. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
16. [A multicenter study to determine the efficacy and safety of strontium (89Sr) chloride for palliation of painful bony metastases in cancer patients].
Nishio M; Sano M; Tamaki Y; Fujii H; Shima Y; Fujimoto H; Kubo A; Koizumi K; Tokuda Y; Adachi S; Sumiyoshi Y; Hasegawa T; Eguchi K
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):399-410. PubMed ID: 16334394
[TBL] [Abstract][Full Text] [Related]
17. Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to bone.
Porter AT
Eur Urol; 1994; 26 Suppl 1():20-5. PubMed ID: 7537665
[TBL] [Abstract][Full Text] [Related]
18. Systemic radionuclide therapy with strontium chloride Sr 89 for painful skeletal metastases in prostate and breast cancer.
Patel BR; Flowers WM
South Med J; 1997 May; 90(5):506-8. PubMed ID: 9160068
[TBL] [Abstract][Full Text] [Related]
19. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
Dafermou A; Colamussi P; Giganti M; Cittanti C; Bestagno M; Piffanelli A
Eur J Nucl Med; 2001 Jul; 28(7):788-98. PubMed ID: 11504074
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases.
Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H
Ann Acad Med Stetin; 2011; 57(1):49-53; discussion 53. PubMed ID: 22593991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]